Alterity Therapeutics (ATHE) Payables (2015 - 2025)

Alterity Therapeutics has reported Payables for 11 years, with the latest figure at $1.0 million in Q4 2025.

• For the quarter ending Q4 2025, Payables fell 21.85% year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2025 stood at $1.0 million (down 21.85% YoY), and the FY2025 full-year result was $1.6 million, down 45.83% from the prior year.
• Payables for Q4 2025 stood at $1.0 million, down from $1.6 million in the prior quarter.
• The five-year high for Payables was $3.6 million in Q2 2022, with the low at $35177.1 in Q2 2023.
• Average Payables over 5 years is $1.7 million, with a median of $1.8 million recorded in 2021.
• Year-over-year, Payables slumped 99.03% in 2023 and jumped 3470.23% in 2025.
• Tracing ATHE's Payables over 5 years: stood at $2.3 million in 2021, then rose by 27.9% to $2.9 million in 2022, then fell by 19.05% to $2.4 million in 2023, then sank by 43.27% to $1.3 million in 2024, then declined by 21.85% to $1.0 million in 2025.
• The last three Payables figures came in at $1.0 million (Q4 2025), $1.6 million (Q2 2025), and $1.3 million (Q4 2024), per Business Quant data.

Peer Comparison